Elena Ramos García
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elena Ramos García has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ana Belén Enguita
School of Medicine, Complutense University, Pl. de Ramón y Cajal, s/n, Moncloa-Aravaca, 28040 Madrid, Spain
1 shared publication Cristina Martín-Arriscado Arroba
Unidad de Investigación y Soporte Científico (Instituto de Investigación imas12), Hospital Universitario 12 de Octubre, Madrid
1 shared publicationElena Vacas Sánchez
Servicio de Cirugía Ortopédica y Traumatología del Hospital Universitario 12 de Octubre, Madrid
1 shared publication- Gabriel Rubio
Departamento de Psiquiatria, Universidad Complutense de Madrid, Instituto de Investigación i+12, Hospital Universitario 12 de Octubre de Madrid, 28041 Madrid, Spain
1 shared publication Gabriel Rubio Valladolid
Servicio de Psiquiatría del Hospital Universitario 12 de Octubre, Madrid
1 shared publication- Jesús Vila-Rico
Department of Trauma and Orthopaedics Surgery, University Hospital 12 de Octubre, Av/Córdoba, s/n, Usera, 28041 Madrid, Spain
1 shared publication
Latest Publications
- Open Access
- 24 June 2026
- Published by Elsevier in Revista Española de Cirugía Ortopédica y Traumatología
IMPACTO DEL DIAGNÓSTICO DE UN SARCOMA MÚSCULO-ESQUELÉTICO Y DE LOS RESULTADOS DE SU TRATAMIENTO EN EL ESTADO ANÍMICO, LA ANSIEDAD, LA CALIDAD DE VIDA Y LAS ESTRATEGIAS DE AFRONTAMIENTO DE LOS PACIENTES
- 24 June 2026
- Published by Elsevier in Revista Española de Cirugía Ortopédica y Traumatología
Open AccessIMPACTO DEL DIAGNÓSTICO DE UN SARCOMA MÚSCULO-ESQUELÉTICO Y DE LOS RESULTADOS DE SU TRATAMIENTO EN EL ESTADO ANÍMICO, LA ANSIEDAD, LA CALIDAD DE VIDA Y LAS ESTRATEGIAS DE AFRONTAMIENTO DE LOS PACIENTES
- Open Access
Leiomyosarcomas of the Great Saphenous Vein: Diagnostic and Therapeutic Strategies to Prevent Unplanned Excisions and Improve Oncologic, Functional, and Psychological Outcomes
Background/Objectives: There are very few publications on unplanned excisions of great saphenous vein leiomyosarcomas (GSV-LMS), and their impact on the prognosis of the disease is not well known. The objective of this study is to present a series of nine new leiomyosarcomas of the great saphena vein (LMS-GSV) cases, with the aim of increasing diagnostic awareness and proposing guidelines for therapeutic management. Methods: This is a prospective single-centre study of a series of nine GSV-LMS in thigh (stage IIIA AJCC), knee and proximal leg (IB, 1 II and 3 IIIA), and ankle (2 IIIB and 1 II). Eight patients were female, and the mean age was 72 years. All patients were surgically treated. Five (56%) were unplanned excisions. All these patients were reoperated on to attempt wide resection margins. In a patient, an infra-patellar amputation was performed. Another amputation was refused by another patient. Eight patients received adjuvant radiotherapy. Results: One patient died 8 years after amputation for a reason other than LMS. The patient who refused amputation has been alive, disease-free, for 28 months. The mean follow-up of surviving patients was 39 months (6–78 months). In these patients, there were no local recurrences or metastases. The mean functional outcome according to the MSTS score was 28.9 (range: 24–30). Conclusions: Unplanned excision of GSV-LMS can be prevented through clinical and imaging suspicion. Surgery and re-excision in case of inadequate previous margins and adjuvant radiotherapy lead to a good oncological and functional outcome.
Open AccessLeiomyosarcomas of the Great Saphenous Vein: Diagnostic and Therapeutic Strategies to Prevent Unplanned Excisions and Improve Oncologic, Functional, and Psychological Outcomes
Background/Objectives: There are very few publications on unplanned excisions of great saphenous vein leiomyosarcomas (GSV-LMS), and their impact on the prognosis of the disease is not well known. The objective of this study is to present a series of nine new leiomyosarcomas of the great saphena vein (LMS-GSV) cases, with the aim of increasing diagnostic awareness and proposing guidelines for therapeutic management. Methods: This is a prospective single-centre study of a series of nine GSV-LMS in thigh (stage IIIA AJCC), knee and proximal leg (IB, 1 II and 3 IIIA), and ankle (2 IIIB and 1 II). Eight patients were female, and the mean age was 72 years. All patients were surgically treated. Five (56%) were unplanned excisions. All these patients were reoperated on to attempt wide resection margins. In a patient, an infra-patellar amputation was performed. Another amputation was refused by another patient. Eight patients received adjuvant radiotherapy. Results: One patient died 8 years after amputation for a reason other than LMS. The patient who refused amputation has been alive, disease-free, for 28 months. The mean follow-up of surviving patients was 39 months (6–78 months). In these patients, there were no local recurrences or metastases. The mean functional outcome according to the MSTS score was 28.9 (range: 24–30). Conclusions: Unplanned excision of GSV-LMS can be prevented through clinical and imaging suspicion. Surgery and re-excision in case of inadequate previous margins and adjuvant radiotherapy lead to a good oncological and functional outcome.